blood cancer

Graphic of a drop of blood made up of small data points and nodes

Biotech

J&J lymphoma CAR-T hits 100% ORR in 10 patients

Of the 10 patients who had received one line of prior treatment, an objective response rate of 100% was recorded.

Darren Incorvaia Jun 13, 2025 1:22pm

rainbow kite flying in the sky

ASCO: Kite's CAR-T flies high in phase 1 B-cell lymphoma study

May 31, 2025 7:00pm

Yellow arrow going opposite direction as white arrows

BioNTech passes on Autolus' CAR-T amid pipeline prioritization

Mar 20, 2025 9:11am

whale jumping out of water

Orca prepares to make market plunge after phase 3 win

Mar 17, 2025 7:00am

An artists 3D rendering of cancerous blood cells among healthy red blood cells The cells fill the image and are of various

Ono pays $280M upfront for Ionis' phase 2 blood cancer med

Mar 12, 2025 6:30am

A series of dice with a bag on them illustrating cost cuts

Ryvu loses 30% of staff in focus on ph. 3 blood cancer trials

Feb 25, 2025 10:00am